Advice
Discontinuation of docetaxel (Taxotere)
The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.
Medicine details
- Medicine name:
- docetaxel (Taxotere)
- SMC ID:
- 42/03
- Indication:
- Unresectable, locally advanced or metastatic (stage III/IV) non-small cell lung cancer.
- Pharmaceutical company
- Aventis
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Full
- Status
- Withdrawn
- Date advice published
- 09 May 2003
Additional notes
The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.